Samjin Pharmaceuticals Co., Ltd.
Samjin Pharmaceuticals Co., Ltd. (KRX: 005500) is trading at ₩20,100.00, about ₹1,451 at today's KRW/INR rate, as of 8 Oct 2026, 2:30 AM ET, up 1.41% today. Samjin Pharmaceuticals is not currently available to trade on Paasa; this page shows its price, statistics and the Indian tax treatment for information.
Quote
Today's low
₩19,710.00
Today's high
₩20,300.00
52 week low
₩16,580.00
52 week high
₩25,900.00
005500 opened at ₩19,710.00, closed previously at ₩19,820.00, and has traded between ₩16,580.00 and ₩25,900.00 over the past 52 weeks.
About
Samjin Pharmaceuticals Co., Ltd. is a South Korean company focused on the discovery and development of pharmaceutical products. Their current portfolio includes SA001, a Phase II clinical asset targeting dry eye and Sjögren's syndrome. In the preclinical stage, they are advancing SJP1803/1804 for macular degeneration, alongside SJP601 and SJP1602, which are designed to combat cancer. Additionally, SPJ1604 and SPJ003 are in clinical phases for treating cancer and diabetes. A broader range of candidates, including SJP1901, SJP1902, SJP1801, and SJP006, are undergoing biological testing for potential applications across cancer, fibrosis, cancer immunotherapy, Alzheimer's disease, Parkinson's disease, and anti-viral conditions. The company was founded in 1968 and is based in Seoul, South Korea.
Key statistics
Avg. volume
173.67K
Market cap
₩254.42B
P/E Ratio
10.75
Price-to-sales ratio
0.82
Enterprise value
₩365.79B
Free cash flow yield
4.12%
Debt-to-equity ratio
0.43
Return on equity
8.32%
ROIC
5.73%
Beta
0.06
Dividend yield
3.98%
Last dividend
₩800.00
Financial overview
Revenue
₩309.13B
Earnings per share
₩1,962.68
Free cash flow
₩9.96B
Net profit margin
7.47%
Gross margin
45.63%
EBITDA
₩44.50B
Revenue growth
0.25%
Similar securities
This is not an investment recommendation
Samjin Pharmaceuticals for Indian investors
Samjin Pharmaceuticals is listed on the Korea Exchange. It is not currently available to trade on Paasa; the figures on this page are for information, and the tax notes below apply to Indian residents who hold it.
Taxes on Samjin Pharmaceuticals for Indian residents
Trading and limits
- Trading hours
- 9:00 am – 3:30 pm KST
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- Slab rateDividends are taxed at your slab rate in India. Samjin Pharmaceuticals’ current yield is 3.98%.Dividend tax explained
FAQs
Can I buy Samjin Pharmaceuticals on Paasa?
Samjin Pharmaceuticals (005500) has been listed on the Korea Exchange since 2005, in the Drug Manufacturers - Specialty & Generic industry. Samjin Pharmaceuticals is not currently available to trade on Paasa; the figures on this page are for information. Indian residents who hold it through another broker still declare it under the rules below.
How much does one Samjin Pharmaceuticals share cost in rupees?
One Samjin Pharmaceuticals share is ₩20,100.00 — about ₹1,451 at a KRW/INR rate of 0.0722 on 8 Oct 2026. Both the Samjin Pharmaceuticals price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for investing abroad from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability.
How are gains on Samjin Pharmaceuticals shares taxed in India?
Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the KRW/INR rate on the purchase and the sale date, so the rupee move counts alongside the Samjin Pharmaceuticals price.
Does Samjin Pharmaceuticals pay a dividend, and how is it taxed in India?
Yes. Samjin Pharmaceuticals pays a dividend and the current yield is 3.98%; the last declared dividend was ₩800.00 per share, about ₹57.74. Dividends are taxed at your slab rate in India.
When does KRX trade, in Indian time?
The Korea Exchange trades 5:30 am – 12:00 pm IST in Indian time.
Do I have to declare Samjin Pharmaceuticals shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. The holding is reported with its cost and its closing value.
Does the rupee rate affect what I make on Samjin Pharmaceuticals?
Yes. Samjin Pharmaceuticals is priced in KRW, so your rupee outcome combines the KRW move with the KRW/INR move between the day you remit and the day you convert back.